US equities
|
MU
$892.10
▼-4.20%
TSLA
$351.85
▼-2.92%
NVDA
$214.50
▼-1.26%
AAPL
$341.66
▼-0.10%
SPCX
$144.31
▼-2.90%
META
$706.82
▼-4.06%
MSFT
$526.76
▼-2.35%
SNDK
$1,321.31
▼-5.27%
MU
$892.10
▼-4.20%
TSLA
$351.85
▼-2.92%
NVDA
$214.50
▼-1.26%
AAPL
$341.66
▼-0.10%
SPCX
$144.31
▼-2.90%
META
$706.82
▼-4.06%
MSFT
$526.76
▼-2.35%
SNDK
$1,321.31
▼-5.27%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about COMP005
Recent news which mentions COMP005
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
October 31, 2024
Tickers
CMPS
NEWS
Tags
Benzinga
Kabir Nath
Psychedelics Research
From
Benzinga